917TiP - Phase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations
| Autor: | Rodríguez-Vida, A., Pérez-Gracia, J.L., Taus, A., Bonfill, T., Vázquez-Mazón, F.J., Galtes, S., Pons, B., Cano, L., Macia, S., Maroto, P., Bellmunt, J. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|